Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells
- 1 March 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (6), 477-486
- https://doi.org/10.1038/sj.gt.3301426
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 48 references indexed in Scilit:
- Progress in the Use of Gene Transfer Methods to Treat Genetic Blood DiseasesHuman Gene Therapy, 2000
- CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified CellsMolecular Therapy, 2000
- A Defined Window for Efficient Gene Marking of Severe Combined Immunodeficient-Repopulating Cells Using a Gibbon Ape Leukemia Virus-Pseudotyped Retroviral VectorHuman Gene Therapy, 2000
- Dose-Dependent Transduction of Vesicular Stomatitis Virus G Protein-Pseudotyped Retrovirus Vector into Human Solid Tumor Cell Lines and Murine FibroblastsVirology, 1999
- Generation of Destabilized Green Fluorescent Protein as a Transcription ReporterJournal of Biological Chemistry, 1998
- Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant RetrovirusHuman Gene Therapy, 1996
- Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cellsNature Biotechnology, 1996
- Gene marking and gene therapy directed at primary hematopoietic cellsCurrent Opinion in Hematology, 1996
- Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.The Journal of Experimental Medicine, 1987
- Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouseNature, 1984